Personalized medicine: new genomics, old lessons

door Offit, Kenneth
Gepubliceerd in 2011

The Future of Clinical Cancer Genomics

door Offit, Kenneth
Gepubliceerd in Semin Oncol (2016)

Heterozygous Mutations in DNA Repair Genes and Hereditary Breast Cancer: A Question of Power

door Ellis, Nathan A., Offit, Kenneth
Gepubliceerd in 2012

Ethical and Legal Implications of Cancer Genetic Testing: Do Physicians Have a Duty to Warn Patients' Relatives About Possible Genetic Risks?

door Storm, Courtney, Agarwal, Rinki, Offit, Kenneth
Gepubliceerd in 2008

Association of a HOXB13 Variant with Breast Cancer

door Alanee, Shaheen, Couch, Fergus, Offit, Kenneth
Gepubliceerd in 2012

Revealing the Incidentalome When Targeting the Tumor Genome

door Bombard, Yvonne, Robson, Mark, Offit, Kenneth
Gepubliceerd in 2013

Genitourinary Cancers Other than Prostate Cancer in a BRCA-tested Cohort from a Single Institution

door Alanee, Shaheen, Schrader, Kasmintan, Offit, Kenneth
Gepubliceerd in Eur Urol (2015)

Two Decades After BRCA: Setting Paradigms in Personalized Cancer Care and Prevention

door Couch, Fergus J., Nathanson, Katherine L., Offit, Kenneth
Gepubliceerd in 2014

A Rapid and Reliable Test for BRCA1 and BRCA2 Founder Mutation Analysis in Paraffin Tissue Using Pyrosequencing

door Zhang, Liying, Kirchhoff, Tomas, Yee, Cindy J., Offit, Kenneth
Gepubliceerd in 2009

Genomic Biomarkers for Breast Cancer Risk

door Walsh, Michael F., Nathanson, Katherine L., Couch, Fergus J., Offit, Kenneth
Gepubliceerd in Adv Exp Med Biol (2016)

Cancer Genomics and Inherited Risk

door Stadler, Zsofia K., Schrader, Kasmintan A., Vijai, Joseph, Robson, Mark E., Offit, Kenneth
Gepubliceerd in J Clin Oncol (2014)

Tissue-Specific Enrichment of Lymphoma Risk Loci in Regulatory Elements

door Hayes, James E., Trynka, Gosia, Vijai, Joseph, Offit, Kenneth, Raychaudhuri, Soumya, Klein, Robert J.
Gepubliceerd in PLoS One (2015)

Absence of loss of heterozygosity of BRCA1 in a renal tumor from a BRCA1 germline mutation carrier

door Alanee, Shaheen, Shah, Sohela, Murali, Rajmohan, Rau-Murthy, Rohini, Schrader, Kasmintan A., Offit, Kenneth
Gepubliceerd in Fam Cancer (2013)

Gene Patents and Personalized Cancer Care: Impact of the Myriad Case on Clinical Oncology

door Offit, Kenneth, Bradbury, Angela, Storm, Courtney, Merz, Jon F., Noonan, Kevin E., Spence, Rebecca
Gepubliceerd in J Clin Oncol (2013)

A case for expert curation: an overview of cancer curation in the Clinical Genome Resource (ClinGen)

door Ritter, Deborah I., Rao, Shruti, Kulkarni, Shashikant, Madhavan, Subha, Offit, Kenneth, Plon, Sharon E.
Gepubliceerd in Cold Spring Harb Mol Case Stud (2019)

Genetics, Genomics and Cancer Risk Assessment: State of the art and future directions in the era of personalized medicine

door Weitzel, Jeffrey N., Blazer, Kathleen R., MacDonald, Deborah J., Culver, Julie O., Offit, Kenneth
Gepubliceerd in 2011

Variants at IRX4 as prostate cancer expression quantitative trait loci

door Xu, Xing, Hussain, Wasay M, Vijai, Joseph, Offit, Kenneth, Rubin, Mark A, Demichelis, Francesca, Klein, Robert J
Gepubliceerd in 2014

Polymorphisms of ADIPOQ and ADIPOR1 and prostate cancer risk

door Kaklamani, Virginia, Yi, Nengjun, Zhang, Kui, Sadim, Maureen, Offit, Kenneth, Oddoux, Carole, Ostrer, Harry, Mantzoros, Christos, Pasche, Boris
Gepubliceerd in 2011

Variants of the Adiponectin and Adiponectin Receptor 1 Genes and Breast Cancer Risk

door Kaklamani, Virginia G., Sadim, Maureen, Hsi, Alex, Offit, Kenneth, Oddoux, Carole, Ostrer, Harry, Ahsan, Habibul, Pasche, Boris, Mantzoros, Christos
Gepubliceerd in 2008

Prevalence of HOXB13 mutation in a population of Ashkenazi Jewish men treated for prostate cancer

door Alanee, Shaheen, Shah, Sohela, Vijai, Joseph, Schrader, Kasmintan, Rau-Murthy, Rohini, Sarrel, Kara, Manschreck, Christopher, Eastham, James, Offit, Kenneth
Gepubliceerd in Fam Cancer (2013)